Tumor infiltrating lymphocytes (TILs) are a prognosis biomarker in Colombian patients with triple negative breast cancer.
Saved in:
| Title: | Tumor infiltrating lymphocytes (TILs) are a prognosis biomarker in Colombian patients with triple negative breast cancer. |
|---|---|
| Authors: | Huertas-Caro CA; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia., Ramírez MA; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia., Rey-Vargas L; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia., Bejarano-Rivera LM; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia., Ballen DF; Clinical Oncology Unit. Instituto Nacional de Cancerología and Adjunct Clinical Professor, Pontificia Universidad Javeriana, Bogotá, DC, Colombia., Nuñez M; Research Support and Follow-Up Group, National Cancer Institute of Colombia, Calle 1 No. 9 -85, Bogotá, DC, Colombia., Mejía JC; Grupo de Patología, Instituto Nacional de Cancerología, Bogotá, Colombia., Sua-Villegas LF; Department of Pathology and Laboratory Medicine, Fundación Valle del Lili, and Faculty of Health Sciences, Universidad ICESI, Cali, Colombia., Cock-Rada A; Department of Oncological Breast Surgery and Mastology, Instituto de Cancerología Las Américas, Medellín, Colombia., Zabaleta J; Department of Interdisciplinary Oncology and Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA., Fejerman L; Department of Public Health Sciences, University of California Davis, Davis, CA, USA.; UC Davis Comprehensive Cancer Center, University of California Davis, Davis, CA, USA., Sanabria-Salas MC; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia., Serrano-Gomez SJ; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia. silviajserrano@gmail.com.; Research Support and Follow-Up Group, National Cancer Institute of Colombia, Calle 1 No. 9 -85, Bogotá, DC, Colombia. silviajserrano@gmail.com. |
| Source: | Scientific reports [Sci Rep] 2023 Dec 03; Vol. 13 (1), pp. 21324. Date of Electronic Publication: 2023 Dec 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2045-2322 |
|---|---|
| DOI: | 10.1038/s41598-023-48300-4 |
